Back to search

Switzerland· 56828001

InductOs 1.5 mg/ml, poudre 12 mg, solvant et matrice pour matrice pour implantation

A dibotermin alfa product containing diboterminum alfa, registered in Switzerland by Medtronic BioPharma Sàrl and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.

Cat B (Swissmedic)ATC M05BC01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedInductOs 1.5 mg/ml, poudre 12 mg, sol…ATCM05BC01REGISTER NO.56828001PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Dibotermin alfa is registered in 11 of 19 countries.

Countries holding a registration under ATC M05BC01 (dibotermin alfa), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Dibotermin alfa · ATC M05BC01

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
diboterminum alfa
Manufacturer
Medtronic BioPharma Sàrl
Country
Switzerland (CH)
ATC code
M05BC01
ATC class
Dibotermin alfa
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dibotermin alfa in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dibotermin alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Inductos
  • Liechtenstein · Inductos
  • Norway · Inductos

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a22932ae-22f3-4371-bd8b-6dfd0ad5d6a9
GET /v1/drugs/a22932ae-22f3-4371-bd8b-6dfd0ad5d6a9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Biotechnologika"
}

See everything about dibotermin alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.